Clinical Trial Update: Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a personalized neo-antigen peptide vaccine for advanced cancers (metastatic breast cancer, melanoma, and non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Personalized Neo-Antigen Peptide Vaccine

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 1 | Status: RECRUITING